TY  - JOUR
T1  - EPigenetic therapies offer new approach to fighting cancer at the genetic level
AU  - Friedrich MJ
Y1  - 2010/01/20
N1  - 10.1001/jama.2009.1914
JO  - JAMA
SP  - 213
EP  - 214
VL  - 303
IS  - 3
N2  - 
Three drugs that target epigenetic pathways are now used in the clinic to treat hematologic malignancies, and many more agents are in the pipeline. Oncologists are taking lessons learned at the bedside back to the bench to better understand how these therapies work and how resistance to them develops, said Jean-Pierre Issa, MD, professor of medicine at the University of Texas M. D. Anderson Cancer Center in Houston.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.1914
UR  - http://dx.doi.org/10.1001/jama.2009.1914
ER  -